Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer.

BMC Cancer · 2022 · PMC8962250 · PMID 35346102

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Furthermore, the change in NLR was the highest in the decreased SMI group (0.62 ± 1.99) and showed a decreasing trend toward the maintained (0.54 ± 1.74) and increased (0.20 ± 1.31) SMI groups in this order.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.